Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71

Journal of Virological Methods

Volumn 186, Issue 1-2, 2012, Pages 193-197

  Ku, Zhiqiang ^a   Shi, Jinping ^a   Liu, Qingwei ^a   Huang, Zhong ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

Enterovirus 71; Monoclonal antibody; Neutralization; Virus like particle

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; PROTEIN VP0; PROTEIN VP1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFICACY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; ENZYME INHIBITION; FEMALE; HYBRIDOMA; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CHILD, PRESCHOOL; ENTEROVIRUS A, HUMAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MICE; MICE, INBRED BALB C;

HUMAN ENTEROVIRUS 71; MURINAE; MUS; PICORNAVIRIDAE;

EID: 84869081301     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.06.025     Document Type: Article

References (18)

1. Chang G.H., Luo Y.J., Wu X.Y., Si B.Y., Lin L., Zhu Q.Y. Monoclonal antibody induced with inactivated EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection. Virology Journal 2010, 7:106.
2. Chang H.W., Liu C.C., Lin M.H., Ho H.M., Yang Y.T., Chow Y.H., Chong P., Sia C. Generation of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolates. Journal of Virological Methods 2011, 173:189-195.
3. Chen H.F., Chang M.H., Chiang B.L., Jeng S.T. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 2006, 24:2944-2951.
4. Chen H.L., Huang J.Y., Chu T.W., Tsai T.C., Hung C.M., Lin C.C., Liu F.C., Wang L.C., Chen Y.J., Lin M.F., Chen C.M. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine 2008, 26:2882-2889.
5. Chung Y.C., Ho M.S., Wu J.C., Chen W.J., Huang J.H., Chou S.T., Hu Y.C. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008, 26:1855-1862.
6. Chung Y.C., Huang J.H., Lai C.W., Sheng H.C., Shih S.R., Ho M.S., Hu Y.C. Expression, purification and characterization of enterovirus-71 virus-like particles. World Journal of Gastroenterology 2006, 12:921-927.
7. Feltes T.F., Sondheimer H.M. Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease. Expert Opinion on Biological Therapy 2007, 7:1471-1480.
8. Feng Y.F., Liu Q.W., Ku Z.Q., Wen J.J., Shan H., Huang Z. Expression of VP0 protein of enterovirus 71 in Escherichia coli and generation of the corresponding polyclonal antibodies in guinea pigs. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2011, 27:535-538.
9. Foo D.G., Alonso S., Phoon M.C., Ramachandran N.P., Chow V.T., Poh C.L. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Research 2007, 125:61-68.
10. Lee M.S., Chang L.Y. Development of enterovirus 71 vaccines. Expert Review of Vaccines 2010, 9:149-156.
11. Lee T.C., Guo H.R., Su H.J., Yang Y.C., Chang H.L., Chen K.T. Diseases caused by enterovirus 71 infection. Pediatric Infectious Disease Journal 2009, 28:904-910.
12. Li X., Mao C., Ma S., Wang X., Sun Z., Yi Y., Guo M., Shen X., Sun L., Bi S. Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides. Biochemical and Biophysical Research Communications 2009, 390:1126-1128.
13. Marasco W.A., Sui J. The growth and potential of human antiviral monoclonal antibody therapeutics. Nature Biotechnology 2007, 25:1421-1434.
14. Reed L.J.M.H. A simple method of estimating 50 percent endpoints. American Journal of Hygiene 1938, 27:493-499.
15. Sivasamugham L.A., Cardosa M.J., Tan W.S., Yusoff K. Recombinant Newcastle Disease virus capsids displaying enterovirus 71 VP1 fragment induce a strong immune response in rabbits. Journal of Medical Virology 2006, 78:1096-1104.
16. Wong S.S., Yip C.C., Lau S.K., Yuen K.Y. Human enterovirus 71 and hand, foot and mouth disease. Epidemiology and Infection 2010, 138:1071-1089.
17. Wu C.N., Lin Y.C., Fann C., Liao N.S., Shih S.R., Ho M.S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2001, 20:895-904.
18. Xu J., Qian Y., Wang S., Serrano J.M., Li W., Huang Z., Lu S. EV71: an emerging infectious disease vaccine target in the Far East?. Vaccine 2010, 28:3516-3521.